Peter J. van Bladeren spends much of his time researching Biochemistry, Efflux, Glutathione, Metabolism and Myricetin. His studies deal with areas such as Microbiome, Stereochemistry, Pharmacology and Microbiology as well as Biochemistry. His research investigates the connection between Efflux and topics such as Transport protein that intersect with problems in Transcellular, Bioavailability and Neuronal signal transduction.
The various areas that Peter J. van Bladeren examines in his Glutathione study include Vesicle and Molecular biology. His Metabolism research is multidisciplinary, incorporating elements of Pro-oxidant, Systems biology, Quinone methide, Quinone and Adduct. As part of one scientific family, he deals mainly with the area of Myricetin, narrowing it down to issues related to the Luteolin, and often Fisetin.
Peter J. van Bladeren mainly investigates Biochemistry, Pharmacology, Estragole, Metabolite and Glutathione. His research is interdisciplinary, bridging the disciplines of In vivo and Biochemistry. Peter J. van Bladeren interconnects Myricetin, Glucuronidation, Toxicity and Drug metabolism in the investigation of issues within Pharmacology.
His work on Glutathione S-transferase as part of general Glutathione research is frequently linked to Conjugate, thereby connecting diverse disciplines of science. His Carcinogen research incorporates themes from Adduct, Glucuronide and Metabolic pathway. His Metabolism study integrates concerns from other disciplines, such as Microsome and Systems biology.
Peter J. van Bladeren focuses on Biochemistry, Estragole, Metabolite, Carcinogen and Pharmacology. His Hesperetin, Flavonoid, Drug metabolism, In vitro and Intestinal absorption study are his primary interests in Biochemistry. His study on Metabolite is mostly dedicated to connecting different topics, such as Metabolism.
He combines subjects such as Microsome and Systems biology with his study of Metabolism. His research investigates the connection with Carcinogen and areas like Adduct which intersect with concerns in DNA. His Pharmacology study incorporates themes from Glucuronidation and Detoxification.
His main research concerns Biochemistry, Hesperetin, Orange juice, Metabolite and Metabolism. His work on Flavonoid, In vitro and Xenobiotic as part of general Biochemistry study is frequently linked to Aglycone and Glycogenesis, bridging the gap between disciplines. His study in In vitro is interdisciplinary in nature, drawing from both Adduct, DNA and In vivo.
Peter J. van Bladeren merges In vivo with Estragole in his study. As part of the same scientific family, he usually focuses on Hesperetin, concentrating on Flavanone and intersecting with Quercetin, Intestinal absorption and Efflux. His biological study spans a wide range of topics, including Microsome, UGT2B7, Glucuronidation, Systems biology and Glycosyltransferase.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model
Francois-Pierre J. Martin;Francois-Pierre J. Martin;Marc-Emmanuel Dumas;Yulan Wang;Cristina Legido-Quigley.
Molecular Systems Biology (2007)
Probiotic modulation of symbiotic gut microbial–host metabolic interactions in a humanized microbiome mouse model
Francois-Pierre J. Martin;Francois-Pierre J. Martin;Yulan Wang;Norbert Sprenger;Ivan K S Yap.
Molecular Systems Biology (2008)
Colonization-Induced Host-Gut Microbial Metabolic Interaction
Sandrine P. Claus;Sandrine L. Ellero;Bernard Berger;Lutz Krause.
Mbio (2011)
Glutathione conjugation as a bioactivation reaction.
Peter J van Bladeren.
Chemico-Biological Interactions (2000)
Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2.
Jelmer J. van Zanden;Heleen M. Wortelboer;Sabina Bijlsma;Ans Punt.
Biochemical Pharmacology (2005)
The case for strategic international alliances to harness nutritional genomics for public and personal health
Jim Kaput;Jose M. Ordovas;Lynnette Ferguson;Ben van Ommen.
British Journal of Nutrition (2005)
Human Metabolic Phenotypes Link Directly to Specific Dietary Preferences in Healthy Individuals
Serge Rezzi;Ziad Ramadan;François-Pierre J Martin;Laurent B Fay.
Journal of Proteome Research (2007)
Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its glutathione conjugate
Jan H.T.M. Ploemen;Ben van Ommen;Peter J. van Bladeren.
Biochemical Pharmacology (1990)
The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE2 synthesis and cytotoxicity in human colorectal carcinoma cell lines
Yvonne E.M. Dommels;Merel M.G. Haring;Nynke G.M. Keestra;Gerrit M. Alink.
Carcinogenesis (2003)
Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1
Raymond Evers;Nicole H.P Cnubben;Jan Wijnholds;Liesbeth van Deemter.
FEBS Letters (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Wageningen University & Research
Netherlands Organisation for Applied Scientific Research
Monash University
Wageningen University & Research
Nestlé (Switzerland)
Murdoch University
Imperial College London
Nanyang Technological University
Imperial College London
Nestlé (Switzerland)
MIT
University of Illinois at Urbana-Champaign
Pennsylvania State University
University of Pavia
Utrecht University
University of Innsbruck
Leiden University
École Polytechnique Fédérale de Lausanne
University of Wisconsin–Madison
Cornell University
Universita della Svizzera Italiana
University of Leicester
University of California, Los Angeles
University of North Carolina at Chapel Hill
Northwell Health
International Agency For Research On Cancer